Protease inhibitors

BMS 100 mg 3623 Pill - blue & white capsule-shape, 18mm

Generic Name: atazanavir

Pill with imprint BMS 100 mg 3623 is Blue & White, Capsule-shape and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 100 mg 3623-100 mg-Blue & White-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 100 mg 3623-100 mg-Blue & White-Capsule-shape

Reyataz
Generic Name: atazanavir [ a-ta-zan-a-vir ]
Imprint: BMS 100 mg 3623
Strength: 100 mg
Color: Blue & White
Size: 18.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Protease inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00003-3623 (Discontinued)
Inactive Ingredients: Crospovidone, Lactose monohydrate, Magnesium stearate, Gelatin, FD&C Blue No. 2, Titanium dioxide, Ferric oxide red, Ferric oxide yellow, Isopropyl alcohol, Ammonia, Propylene glycol, Butyl alcohol, Alcohol, Ferrosoferric oxide, Shellac,
Latest News
Related Drugs